2011年8月下旬,Hope制药公司的氰化物急性中毒用解毒剂Nithiodote在美国正式获准上市。Nithiodote实为由亚硝酸钠(sodium nitrite)注射液和硫代硫酸钠(sodium thiosulfate)注射液组成的一种制剂包,系经优先审批程序获得FDA批准的,是FDA迄今批准含有亚硝酸钠或硫代硫酸钠的第一个药物。氰化物中毒的原因主要包括工业事故、自杀或恐怖袭击等。氰化物进入体内后会阻 In late August 2011, hope pharmaceutical company cyanide acute poisoning antidote Nithiodote officially approved in the United States. Nithiodote is actually a preparation package consisting of sodium nitrite injection and sodium thiosulfate injection, approved by the FDA under the priority approval procedure, to date by the FDA for the approval of pharmaceuticals containing sodium nitrite or The first drug of sodium thiosulfate. The causes of cyanide poisoning mainly include industrial accidents, suicide or terrorist attacks. Cyanide will be blocked after entering the body